Call us now :08071793621
Send Inquiry
Send InquiryCycloxan 200 mg Injection
Cycloxan 200 mg Injection Specification
- Origin of Medicine
- Synthetic
- Salt Composition
- Cyclophosphamide
- Pacakaging (Quantity Per Box)
- 1 vial per box
- Ingredients
- Cyclophosphamide
- Recommended For
- Patients requiring chemotherapy or immune system suppression
- Dosage
- 200 mg
- Dosage Guidelines
- As prescribed by a healthcare professional; administered intravenously
- Quantity
- 1 vial
- Storage Instructions
- Store in a cool dry place below 25°C; protect from light
About Cycloxan 200 mg Injection
Cycloxan 200 mg Injection is a potent medication containing Cyclophosphamide, primarily utilized for chemotherapy and immune system suppression. It is administered intravenously as per the dosage guidelines prescribed by a healthcare professional. Each box contains 1 vial of 200 mg. The synthetic origin of the medicine ensures consistent quality. To maintain its efficacy, store the injection in a cool, dry place below 25C and shield from light.
FAQs of Cycloxan 200 mg Injection:
Q: What is Cycloxan 200 mg Injection used for?
A: Cycloxan 200 mg Injection is primarily used for patients requiring chemotherapy or immune system suppression.Q: How should Cycloxan 200 mg Injection be administered?
A: Cycloxan 200 mg Injection is administered intravenously as prescribed by a healthcare professional.Q: How many vials are included in each box of Cycloxan 200 mg Injection?
A: Each box contains 1 vial of 200 mg Cycloxan Injection.Q: What is the storage recommendation for Cycloxan 200 mg Injection?
A: It is advised to store Cycloxan 200 mg Injection in a cool, dry place below 25C and protect it from light.Q: What is the main ingredient in Cycloxan 200 mg Injection?
A: The main ingredient in Cycloxan 200 mg Injection is Cyclophosphamide.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
More Products in Anti-Cancer Category
Amgicin 200 mg Injection
Recommended For : Patients with severe bacterial infections
Storage Instructions : Store at 2C to 8C keep away from light
Ingredients : Amikacin Sulphate
Quantity : 1 vial
Origin of Medicine : Allopathic
Dosage : 200 mg
Lenvat 10 mg Capsule
Recommended For : Patients with thyroid cancer kidney cancer (renal cell carcinoma) or liver cancer (hepatocellular carcinoma).
Storage Instructions : Store below 30C in a cool dry place away from sunlight. Keep out of reach of children.
Ingredients : Lenvatinib
Quantity : Pack of 30 Capsules
Origin of Medicine : Synthetic
Dosage : 10 mg
Gros 30 mg Injection
Recommended For : Target conditions or patient demographics (e.g. adults specific diseases)
Storage Instructions : Store in a cool dry place away from light and heat
Ingredients : Active salt composition or key ingredients of Gros 30 mg Injection
Quantity : Unit count or volume per vial (e.g. 1 vial 10 vials etc.)
Origin of Medicine : Indicates if it is Allopathic Ayurvedic Homeopathic etc.
Dosage : 30 mg
Alrubicin 10 mg Injection
Recommended For : Patients undergoing chemotherapy for cancer treatment
Storage Instructions : Store in a refrigerator at 2C to 8C (36F to 46F) protect from light
Ingredients : Doxorubicin Hydrochloride
Quantity : 1 vial
Origin of Medicine : Synthetic
Dosage : 10 mg per dose
Send InquiryOur Products
- Alzheimers
- Anti-Cancer
- Anti-Fungal
- Anti-Viral
- Arthritis
- Blood Disorder
- Bone Disease
- Bone Marrow Disorder
- Bowel Disease
- Critical Care
- Gynaecology
- Liver Disease
- Lung Disease
- Macular Degeneration
- Multiple Sclerosis
- Nausea
- Nephrology
- Organ Transplant
- Orthostatic Hypotension
- Osteoporsis
- Psoriasis
- Skin Disorder
- Vaccines
- Pharmaceutical Injection
- Enoxaparin Sodium Medicine
- Oral Suspension
- Pharmaceutical Tablets
- Allopathic Medicine
229, Metro Mall, Bapa Sitaram Chowk, Opp. RAF Camp, S.P. Ring Road, Vastral, Ahmedabad - 382418, Gujarat, India
Dr. Harsh M Patel
(Director)
Mobile :08071793621
Send Inquiry
Send SMS
Developed and Managed by Infocom Network Private Limited.
